ArticlePloS one2025
Deep learning-based classification of peptide analytes from single-channel nanopore translocation events.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Beyond the Static Caliper: Dynamical Translocases and the Mathematical Imperative for Single-Molecule Proteomics.bioRxiv : the preprint server for biology · 2026Article
- Rational Engineering of the Anthrax Toxin Nanopore Interface for Orthogonal Peptide Classification.ACS omega · 2026Article
- Peptide properties predict multistate translocation kinetics via protective antigen nanopores.Biophysical journal · 2026Article
- Dynamic gating by ϕ-clamp loop controls peptide translocation through the anthrax toxin nanopore.Biophysical journal · 2026Article
- A dynamical anthrax toxin nanopore biosensor for high-fidelity single-peptide classification.PLoS computational biology · 2026Article
- Single-molecule sensing with an anthrax nanopore enabled by pH-asymmetric ionic liquids.Journal of nanobiotechnology · 2025Article
Corrections and comments
- Update of
Authors and funding
1 author.
Funding
Abstract
Rapid and accurate detection of peptide biomarkers using nanopore biosensors is critical for disease diagnosis and other biomedical applications. Processing large, complex single-channel translocation data streams poses a significant challenge for peptide analyte classification. Here, we present a supervised deep learning data processing pipeline for peptide classification from translocation events. The first stage employs a convolutional and recurrent neural network, adapted from the Deep-Channel multi-channel classifier, to accurately classify raw current recordings into discrete conductance states, including partially blocked sub-conductance intermediates. The second stage, peptide classification, utilizes a novel branched input network with a temporal convolutional network for processing translocation event conductance state sequences and a dense network for incorporating computed event-level and global kinetic features. Using idealized simulated multi-state translocation data for seven peptides, we demonstrate high classification accuracy (0.9998 (±0.0006)) when global features are included alongside event-level features. For classifying mixture samples, where only event-level features are applicable, performance shows more modest accuracy (0.70 (±0.01)). Peptide mixture predictions showed reasonable accuracy (MAE 0.045-0.161), although misclassification resulted in false positives. Event stochasticity and the fact that some peptides possessed similar kinetic parameters posed challenging for event-level prediction. However, vote aggregation from translocation event streams achieves perfect 100% accuracy, when predicting pure peptide samples. This proof-of-concept study demonstrates a robust deep learning framework for nanopore peptide classification using simulated data, laying the groundwork for classifying peptides from complex mixtures using real experimental data with the anthrax toxin protective antigen nanopore.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.